《Drug Resistance in Oncology》是一本圖書，作者是Bernal, Samuel D.
基本介紹
- 外文名：Drug Resistance in Oncology
- 作者：Bernal, Samuel D.
- 出版時間：1997年8月
- 頁數：416 頁
- ISBN：9780824792954
- 定價：225.94 美元
Drug Resistance in Oncology
相關詞條
- 陳寶安(全國知名血液病與腫瘤學專家)
陳寶安，東南大學醫學院教授，全國知名血液病與腫瘤學專家。個人履歷 現任東南大學附屬中大醫院血液科學科帶頭人、骨髓增生異常綜合徵研究所所長、腫瘤學系主任。兼任中國抗癌協會臨床腫瘤學協作專業委員會執行委員、江蘇省抗癌協會理事、中華醫學會江蘇省血液學會副主任委員、中華醫學會南京血液學會前主任委員。 1979年畢業於...
- Recent Advances in Cancer Research and Therapy(癌症研究及其治療的...
14 Biochemistry and Pharmacology of Human ABCC1/MRP1 and ItsRole in Detoxification and in Multidrug Resistance of CancerChemotherapy 15 The Role of Traditional Chinese Medicine in ClinicalOncology 16 Effect of Arsenic Trioxide on Acute Promyelocytic Leukemiaand Glioma:...
- 李湘奇
NVP-CGM097, anHDM2Inhibitor,Antagonizes ATP-Binding Cassette Subfamily B Member1-Mediated Drug Resistance Frontiers in Oncology Verteporfininhibits cell proliferation and induces apoptosis in different subtypes ofbreast cancer cell lines without light activation Thepotential role and status of IL-17 ...
- 袁中玉(中山大學腫瘤防治中心內科主任醫師、博士生導師)
袁中玉，中山大學腫瘤醫院（中山大學腫瘤防治中心/中山大學附屬腫瘤醫院）內科主任醫師，博士生導師。2003年畢業於中山大學，獲腫瘤學博士學位。主要從事乳腺癌的化療、內分泌治療及靶向治療，尤其專注於三陰乳腺癌的臨床和科研。作為主要研究者主持了多項一、二及三期的臨床研究；承擔國家自然科學基金重點項目、面上項目、...
- Molecular cancer therapeutics
Molecular Cancer Therapeutics strives to be the top choice for publishing the best science in the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug ...
- CELL(1974年首次發刊的《細胞》期刊)
2024年8月27日，上海大學醫學院卞月珉教授與美國哈佛大學醫學院Jonathan Abraham教授團隊合作，作為共同第一作者，在國際頂級期刊《Cell》（《細胞》）上發表題為《Viral DNA polymerase structures reveal mechanisms of antiviral drug resistance》的研究論文。2024年9月，上海交通大學醫學院腫瘤系統醫學全國重點實驗室沈...
- 張曉芳(山東大學基礎醫學院講師)
Xiaofang Zhang, Juan Li, Zhengang Qiu, Xiaojuan Wu, Peng Gao, Genyin Zhou(*).Co-suppression of MDR1 (multidrug resistence 1) and GCS (glucosylceramide synthase) restores sensitivity to mutidrug resistance breast cancer cells by RNA interference (RNAi). Cancer Biol Ther. 2009; 8(12): ...
- 高鵬(山東大學基礎醫學院副院長、黨委委員)
20. Gao P, Zhou Geng Yin, Wu Ya Guang, et al. Expression of cyclin D1 protein in breast tumors and its relationship with genetic alteration. US-chinese journal of lymphology and oncology,2003，2：7-10.21. 高鵬，周庚寅等.細胞表面糖蛋白表達異常與涎腺多形性腺瘤復發的關係.華西口腔醫學雜誌，...
- 江紅(北京交通大學副教授)
Zhang C#, Ma QF#, Shi YN, Li X, Wang M, Wang JF, Ge JL, Chen ZN, WANG ZL and Jiang H*. A novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cell line Eca-109/5-FU with significant drug-resistance-related characteristics. Oncology Reports. 2017, 37: 2942-2954 ...
- 周文(中南大學基礎醫學院腫瘤研究所研究員)
10. Zhou W*, Yang Y*, Xia J*, Wang H*, Salama ME,Xiong W, Xu H, Shetty S, Chen T, Zeng Z, Shi L, Zangari M, Miles R, Bearss D,Tricot G#, Zhan F#. NEK2 induces drug resistance mainly through activation ofefflux drug pumps and is associated with poor prognosis in myeloma ...
- 謝成英
2. 2023年12月16日，臨港實驗室謝成英研究團隊聯合上海科技大學免疫化學研究所免疫化學生物學課題組在國際學術期刊Experimental Hematology & Oncology上發表題為“Targeting ST8SIA6-AS1 counteracts KRASinhibitor resistance through abolishing the reciprocal activation of PLK1/c-Myc signaling”的研究論文。該研究報導...
- 樓宜嘉
9. Zhe Chen, Luoyang Qi, Danyan Zhu, Yijia Lou*: Relationship between activation of microsomal glutathione S-transferase and development of drug resistance on PC-3, K-562 and HepG2 cell lines. The International Congress of Asian Society of Toxicology. JUN. 2006; Zhuhai, China.10. Haifei ...
- 何冬旭
(5) D.X. He, G.Y. Zhang, X.T. Gu, A.Q. Mao, C.X. Lu, J. Jin, D.Q. Liu, X. Ma, Genome-wide profiling of long non-coding RNA expression patterns in anthracycline-resistant breast cancer cells, International Journal of Oncology, 49 (2016) 1695-1703.(6) P. Zhang, D. He...
- 重症監護學英文影印版·上冊
156 Drug-Kidney Interactions George J.Kaloyanides,MD,FACP 157 Acute Renal Failure in Infants and Children Claudio Ronco,MD·Massimo Ronconi, MD Rinaldo Bellomo,MB BS(HONS),MD,FRACP SECTION Ⅺ HEMATOLOGY/ONCOLOGY Section Editor:Jeffrey S.Groeger,MD 158 Bone Marrow Transplantation Edward D.Ball,MD...
- 重症監護學英文影印版·下冊
156 Drug-Kidney Interactions George J.Kaloyanides,MD,FACP 157 Acute Renal Failure in Infants and Children Claudio Ronco,MD·Massimo Ronconi,MD Rinaldo Bellomo,MB BS(HONS),MD,FRACP SECTION Ⅺ HEMATOLOGY/ONCOLOGY Section Editor:Jeffrey S.Groeger,MD 158 Bone Marrow Transplantation Edward D.Ball,MD·...
- 郭志剛(南京師範大學生命科學學院副院長)
Lingfeng He,Hong Zhu,Shiying Zhou, Huan Wu, Huan Yang, Huiwen Mao, Feiyan Pan, Zhigang Hu, GUO Z（郭志剛） * . Wnt pathway is involved in 5-FUdrug resistance of colorectal cancer cells. Experimental & Molecular Medicine (2018) 50 (8) :101 （影響因子5.58） Xiang ...
- 互補試驗
ExpressionofERCC1incolorectalcanceranditsclinicalsignificance ZHUJuan,XIAOJuXiang,ZHANGYanBing,WANGYanHua,CHANGHao,WUJunLan,ZHANGLei,WANGLe DepartmentofMedicalOncology,FirstHospitalofXianJiaotongUniversity,Xian710061,China 【Abstract】AIM:Toexploretheexcisionrepaircrosscomplementing1(ERCC1)...
- 張克明(北京大學國際醫院肝膽外科主任)
1. Wei Z, Hongtao Z, Zhang K* et al.Novel and Specific MRI Features Indicate the Clinical Features of Patients With Rare Hepatic Tumor Epithelioid Hemangioendothelioma. Frontiers in Oncology. 2022;10(6):321-325.2. Chen J, Cheng Z, Cai J, Tian Y, Wu T, Pu C, Shi W, Suo X, ...
- 何永捍
2019-01-01-今,腫瘤學SCI期刊《Current Cancer Drug Targets》, 客座編委 2018-12-31-今,美國血液病協會（The American Society of Hematology, ASH）, 會員 2017-12-31-2018-12-31,遺傳學SCI期刊《Frontiers in Genetics》, 客座編委 2017-12-31-今,美國衰老協會（The Gerontological Society of America, GSA...
- 紀春岩
19. Ji M,Li J, Yu H, Ma D, Ye J, Sun X, Ji C. Simultaneous targeting of MCL1 and MDR1 asa novel strategy to overcome drug resistance in human leukemia. Br J Haematol.2009; 145(5): 648-56.20. Dong C, Ji M, Ji C. Micro-RNAs and theirpotential target genes in leukemia ...
- 高獻書
高獻書，男，主任醫師、教授，博士生導師，現北京大學第一醫院放療科主任，北京大學放射腫瘤學系主任，北京大學近距離治療中心副主任。專業特長為腫瘤的放射治療及綜合診治。1984年畢業於河北醫科大學獲學士學位，1995年於日本岡山大學獲博士學位。曾在日本岡山大學及美國MD Anderson Cancer Center從事放射腫瘤研究。致力於...
- 曾子晏
72. Jianghong Cheng,Mingli Li , Chi-Meng Tzeng , Xingchun Gou and Shuai Chen, Suppression ofTumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast CancerCells via ERK/JNK Pathway. Frontiers in Oncology, 28 July 2021,doi:10.3389/fonc.2021.621500.71. ZhaoY, Lu C, Wang H, Lin...
- 高偉(耳鼻咽喉頭頸外科學博導,教授,主任醫師)
*,Non-coding RNAs in drug resistance of head and neck cancers: A review, Biomedicine & Pharmacotherapy, 2020, 127(2020): 110231(大類分區2區, IF=4.545,通訊作者)15. Dongli Yang#, Yong Shi#, Yemei Tang#, Hongyu Yin,Yujia Guo, Shuxin Wen, Bingquan WANG, Changming An, Yongyan Wu*, ...
- 陳曉光(中國醫學科學院藥物所黨委書記、博士生導師)
中華腫瘤學雜誌等編委。2004年被國家人事部等七部委授予首批新世紀百千萬人才工程國家級人選；2005年獲得國家政府特殊津貼。代表論文 1.Li Yan, Tang Ke, Li Chao, NiuFei, Zhou Wanqi, Yang Hanze, Feng Zhiqiang, Chen Xiaoguang. The molecular mechanisms of a novel multi-kinase inhibitor ZLJ33 in ...
- 杜慶鋒
（16）Fu Y, Gao X, Yu X, Liu X, Du Q*.Ephrin type-B receptor 4 is an essential mediator in drug-resistance of acute myeloid leukemia cells to Adriamycin.J Exp Ther Oncol.2018-11-12;2018 Nov;12(4):249-259.（IF:3.561）（17）Liu H, Wang C, Wang P, Liu N*, Du Q*. A ...
- 武正華
10. Zheqi Li, Zhenghua Wu, Hao Chen, Qi Zhu, Guangwei Gao, Lingyun Hu, Hema Negi, Suchitra Kamle and Dawei Li，Induction of anterior gradient2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-induced breast cancer cell proliferation and migration, Medical Oncology, ...
- 周永昌(香港乳腺癌專家)
Yip AYS, Ong EYY, Chow LWC. Expert Opinion on Drug Safety. 2011 Sep 30 online...[11-9-30]乳腺癌個體化新輔助治療及輔助手段的套用 周 永昌,魯慶榮,葉潤燊. 中國臨床腫瘤學進展2011 (The 14th Annual Meeting of Chinese Society of Clinical Oncology (CSCO) Educational Book, Sep 2011, Article ...
- 梁麗嫻(澳門大學健康科學院教授)
4. Xie Y, Feng SL, He F, Yan PY, Yao XJ, Fan XX, Leung EL*, Zhou H*. Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer. Pharmacological Research. 2022; 186: 106514. (IF=9.3)5. Wang J, ...
- 陳信義(北京東直門血液科專家)
獲得科研成果與獎勵6項，申請專利4項，開發中藥新藥2項，發表臨床與科學研究論文100餘篇，主編《內科診療常規》、《骨髓增生異常綜合徵症治》、《中西醫結合血液病手冊》、《中醫臨床血液病學》、《常見血液病中醫診療範例》等專業著作；參加《中醫腫瘤學》編著，主審《中醫血液病學》；擔任國家中醫藥管理局21世紀...
